Efficacy Confirmation Trial of CDP870 as add-on Medication to Methotrexate (MTX) in Japanese Rheumatoid Arthritis (RA)
Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
The objective of this trial is to investigate the efficacy (American College of Rheumatology
20% : ACR20) superiority of two dose regiments of CDP870 versus placebo in combination with
MTX in active RA patients who have an incomplete response to MTX. The pharmacokinetics and
immunogenicity profile of CDP870 will also be investigated to assess the extrapolability of
foreign data to the Japanese population.